French lab develops a new drug against chronic bowel inflammatory diseases
Marie Werner reports on the development of a new RNA-targeting drug that could reshape treatment for ulcerative colitis.
Marie Werner reports on the development of a new RNA-targeting drug that could reshape treatment for ulcerative colitis.
Niamh Walker reports on a recent, controversial decision by the FDA to approve Tofersen for ALS treatment.
Adèle Bouyer explores the efficacy and challenges of traditional, complementary, and integrative medicine in modern healthcare.
Felicites Rapon explores the advantages of PROTACs over small molecule inhibitors in addressing cancer treatment and drug resistance.
Marianna Birkitt examines the multifaceted applications of microfluidics in biological research, ethical drug testing, and space exploration.
Isabelle Goodall-Summers explores the off-label use of Ozempic for weight loss, highlighting potential societal implications.
Niamh Walker reports on the recent development of AOH1996, a pill targeting cancerous cells, offering a new approach to cancer treatment.
Lily Massey explores the potential of senolytics to combat age-related diseases, possibly improving the quality of human life in later years.
Jamie Adams reviews what we know about tinnitus, and options for treating this mysterious medical condition.
Adèle Bouyer reviews how a recent change in FDA regulation may herald a decline in animal testing, in the face of new alternative models.